Multidisciplinary Approach to Diagnostic Testing in Metastatic Non-Small Cell Lung Cancer
Please join us: Multidisciplinary Approach to Diagnostic Testing in Metastatic Non-Small Cell Lung Cancer Speaker RSVP to
AstraZeneca will comply with any and all federal or state reporting requirements regarding any value or expense associated with this event. AstraZeneca fully supports and abides by the PhRMA Code on interactions with health care professionals (HCPs). This program is open only to HCP invitees. AstraZeneca will not accommodate attendance of a spouse or other guest of any HCP attendee, nor will AstraZeneca pay for transportation or parking costs of attendees. |
|